Evidence for the Use of Intramuscular Injections in Outpatient Practice
There are few studies comparing the outcomes of patients who are treated with oral versus intramuscular antibiotics, corticosteroids, nonsteroidal anti-inflammatory drugs, or vitamin B12 . This may lead to confusion about when the intramuscular route is indicated. For example, intramuscular ceftriax...
Gespeichert in:
Veröffentlicht in: | American family physician 2009-02, Vol.79 (4), p.297-300 |
---|---|
1. Verfasser: | |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 300 |
---|---|
container_issue | 4 |
container_start_page | 297 |
container_title | American family physician |
container_volume | 79 |
creator | Shatsky, Mark, DO |
description | There are few studies comparing the outcomes of patients who are treated with oral versus intramuscular antibiotics, corticosteroids, nonsteroidal anti-inflammatory drugs, or vitamin B12 . This may lead to confusion about when the intramuscular route is indicated. For example, intramuscular ceftriaxone for Neisseria gonorrhoeae infection and intramuscular penicillin G benzathine for Treponema pallidum infection are the treatments of choice. However, oral antibiotics are the treatment of choice for the outpatient treatment of pneumonia and most other outpatient bacterial infections. Oral corticosteroids are as effective as intramuscular corticosteroids and are well-tolerated by most patients. High daily doses of oral vitamin B12 with ongoing clinical surveillance appear to be as effective as intramuscular treatment. Few data support choosing intramuscular ketorolac over an oral nonsteroidal anti-inflammatory drug unless the patient is unable to tolerate an oral medication. For other indications, the intramuscular route should be considered only when the delivery of a medication must be confirmed, such as when a patient cannot tolerate an oral medication, or when compliance is uncertain. |
format | Article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_66951836</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>1_s2_0_S0002838X09600848</els_id><sourcerecordid>66951836</sourcerecordid><originalsourceid>FETCH-LOGICAL-e291t-5b06c8c1031f59037853764c23724270313f48be083c6f2316a27fe071cbb1cc3</originalsourceid><addsrcrecordid>eNpdkE9LAzEUxHNQbK1-BQkevC3kz242exGk1FooVNCCt5BN32LqbrYm2UK_vSmtHjw9ZvgxzJsLNCaEsExy-TFC1yFskywLWl2hEa0YL_JKjNF8trcbcAZw03scPwGvA-C-wQsXve6GYIZW-6S2YKLtXcDW4dUQdzpacBG_ep18AzfostFtgNvznaD18-x9-pItV_PF9GmZAatozIqaCCMNJZw2RUV4KQteitwwXrKclcnmTS5rIJIb0TBOhWZlA6Skpq6pMXyCHk65O99_DxCi6mww0LbaQT8EJURVUMlFAu__gdt-8C51U4znKZhRnqC7MzTUHWzUzttO-4P63ScBjycA0k97C16Z1jprdPsFBwh_kVQFpoh6Oy5-HJxUghCZS_4DVPFzNQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>234316213</pqid></control><display><type>article</type><title>Evidence for the Use of Intramuscular Injections in Outpatient Practice</title><source>MEDLINE</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><creator>Shatsky, Mark, DO</creator><creatorcontrib>Shatsky, Mark, DO</creatorcontrib><description>There are few studies comparing the outcomes of patients who are treated with oral versus intramuscular antibiotics, corticosteroids, nonsteroidal anti-inflammatory drugs, or vitamin B12 . This may lead to confusion about when the intramuscular route is indicated. For example, intramuscular ceftriaxone for Neisseria gonorrhoeae infection and intramuscular penicillin G benzathine for Treponema pallidum infection are the treatments of choice. However, oral antibiotics are the treatment of choice for the outpatient treatment of pneumonia and most other outpatient bacterial infections. Oral corticosteroids are as effective as intramuscular corticosteroids and are well-tolerated by most patients. High daily doses of oral vitamin B12 with ongoing clinical surveillance appear to be as effective as intramuscular treatment. Few data support choosing intramuscular ketorolac over an oral nonsteroidal anti-inflammatory drug unless the patient is unable to tolerate an oral medication. For other indications, the intramuscular route should be considered only when the delivery of a medication must be confirmed, such as when a patient cannot tolerate an oral medication, or when compliance is uncertain.</description><identifier>ISSN: 0002-838X</identifier><identifier>PMID: 19235496</identifier><identifier>CODEN: AFPYBF</identifier><language>eng</language><publisher>United States: American Academy of Family Physicians</publisher><subject><![CDATA[Adrenal Cortex Hormones - administration & dosage ; Ambulatory Care ; Anti-Bacterial Agents - administration & dosage ; Anti-Inflammatory Agents - administration & dosage ; Antibiotics ; Drug therapy ; Family Practice ; Humans ; Infections ; Injections, Intramuscular ; Internal Medicine ; Ketorolac - administration & dosage ; Musculoskeletal system ; Outpatient care facilities ; Staphylococcus infections ; Vitamin B 12 - administration & dosage ; Vitamin B Complex - administration & dosage]]></subject><ispartof>American family physician, 2009-02, Vol.79 (4), p.297-300</ispartof><rights>American Family Physician</rights><rights>Copyright American Academy of Family Physicians Feb 15, 2009</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/19235496$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Shatsky, Mark, DO</creatorcontrib><title>Evidence for the Use of Intramuscular Injections in Outpatient Practice</title><title>American family physician</title><addtitle>Am Fam Physician</addtitle><description>There are few studies comparing the outcomes of patients who are treated with oral versus intramuscular antibiotics, corticosteroids, nonsteroidal anti-inflammatory drugs, or vitamin B12 . This may lead to confusion about when the intramuscular route is indicated. For example, intramuscular ceftriaxone for Neisseria gonorrhoeae infection and intramuscular penicillin G benzathine for Treponema pallidum infection are the treatments of choice. However, oral antibiotics are the treatment of choice for the outpatient treatment of pneumonia and most other outpatient bacterial infections. Oral corticosteroids are as effective as intramuscular corticosteroids and are well-tolerated by most patients. High daily doses of oral vitamin B12 with ongoing clinical surveillance appear to be as effective as intramuscular treatment. Few data support choosing intramuscular ketorolac over an oral nonsteroidal anti-inflammatory drug unless the patient is unable to tolerate an oral medication. For other indications, the intramuscular route should be considered only when the delivery of a medication must be confirmed, such as when a patient cannot tolerate an oral medication, or when compliance is uncertain.</description><subject>Adrenal Cortex Hormones - administration & dosage</subject><subject>Ambulatory Care</subject><subject>Anti-Bacterial Agents - administration & dosage</subject><subject>Anti-Inflammatory Agents - administration & dosage</subject><subject>Antibiotics</subject><subject>Drug therapy</subject><subject>Family Practice</subject><subject>Humans</subject><subject>Infections</subject><subject>Injections, Intramuscular</subject><subject>Internal Medicine</subject><subject>Ketorolac - administration & dosage</subject><subject>Musculoskeletal system</subject><subject>Outpatient care facilities</subject><subject>Staphylococcus infections</subject><subject>Vitamin B 12 - administration & dosage</subject><subject>Vitamin B Complex - administration & dosage</subject><issn>0002-838X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2009</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>BENPR</sourceid><recordid>eNpdkE9LAzEUxHNQbK1-BQkevC3kz242exGk1FooVNCCt5BN32LqbrYm2UK_vSmtHjw9ZvgxzJsLNCaEsExy-TFC1yFskywLWl2hEa0YL_JKjNF8trcbcAZw03scPwGvA-C-wQsXve6GYIZW-6S2YKLtXcDW4dUQdzpacBG_ep18AzfostFtgNvznaD18-x9-pItV_PF9GmZAatozIqaCCMNJZw2RUV4KQteitwwXrKclcnmTS5rIJIb0TBOhWZlA6Skpq6pMXyCHk65O99_DxCi6mww0LbaQT8EJURVUMlFAu__gdt-8C51U4znKZhRnqC7MzTUHWzUzttO-4P63ScBjycA0k97C16Z1jprdPsFBwh_kVQFpoh6Oy5-HJxUghCZS_4DVPFzNQ</recordid><startdate>20090215</startdate><enddate>20090215</enddate><creator>Shatsky, Mark, DO</creator><general>American Academy of Family Physicians</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>3V.</scope><scope>7RV</scope><scope>7X7</scope><scope>7XB</scope><scope>88C</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9-</scope><scope>K9.</scope><scope>KB0</scope><scope>M0R</scope><scope>M0S</scope><scope>M0T</scope><scope>NAPCQ</scope><scope>PHGZM</scope><scope>PHGZT</scope><scope>PJZUB</scope><scope>PKEHL</scope><scope>PPXIY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope></search><sort><creationdate>20090215</creationdate><title>Evidence for the Use of Intramuscular Injections in Outpatient Practice</title><author>Shatsky, Mark, DO</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-e291t-5b06c8c1031f59037853764c23724270313f48be083c6f2316a27fe071cbb1cc3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2009</creationdate><topic>Adrenal Cortex Hormones - administration & dosage</topic><topic>Ambulatory Care</topic><topic>Anti-Bacterial Agents - administration & dosage</topic><topic>Anti-Inflammatory Agents - administration & dosage</topic><topic>Antibiotics</topic><topic>Drug therapy</topic><topic>Family Practice</topic><topic>Humans</topic><topic>Infections</topic><topic>Injections, Intramuscular</topic><topic>Internal Medicine</topic><topic>Ketorolac - administration & dosage</topic><topic>Musculoskeletal system</topic><topic>Outpatient care facilities</topic><topic>Staphylococcus infections</topic><topic>Vitamin B 12 - administration & dosage</topic><topic>Vitamin B Complex - administration & dosage</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Shatsky, Mark, DO</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>ProQuest Central (Corporate)</collection><collection>Nursing & Allied Health Database</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Healthcare Administration Database (Alumni)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>Consumer Health Database (Alumni Edition)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>Consumer Health Database</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Healthcare Administration Database</collection><collection>Nursing & Allied Health Premium</collection><collection>ProQuest Central (New)</collection><collection>ProQuest One Academic (New)</collection><collection>ProQuest Health & Medical Research Collection</collection><collection>ProQuest One Academic Middle East (New)</collection><collection>ProQuest One Health & Nursing</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><jtitle>American family physician</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Shatsky, Mark, DO</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Evidence for the Use of Intramuscular Injections in Outpatient Practice</atitle><jtitle>American family physician</jtitle><addtitle>Am Fam Physician</addtitle><date>2009-02-15</date><risdate>2009</risdate><volume>79</volume><issue>4</issue><spage>297</spage><epage>300</epage><pages>297-300</pages><issn>0002-838X</issn><coden>AFPYBF</coden><abstract>There are few studies comparing the outcomes of patients who are treated with oral versus intramuscular antibiotics, corticosteroids, nonsteroidal anti-inflammatory drugs, or vitamin B12 . This may lead to confusion about when the intramuscular route is indicated. For example, intramuscular ceftriaxone for Neisseria gonorrhoeae infection and intramuscular penicillin G benzathine for Treponema pallidum infection are the treatments of choice. However, oral antibiotics are the treatment of choice for the outpatient treatment of pneumonia and most other outpatient bacterial infections. Oral corticosteroids are as effective as intramuscular corticosteroids and are well-tolerated by most patients. High daily doses of oral vitamin B12 with ongoing clinical surveillance appear to be as effective as intramuscular treatment. Few data support choosing intramuscular ketorolac over an oral nonsteroidal anti-inflammatory drug unless the patient is unable to tolerate an oral medication. For other indications, the intramuscular route should be considered only when the delivery of a medication must be confirmed, such as when a patient cannot tolerate an oral medication, or when compliance is uncertain.</abstract><cop>United States</cop><pub>American Academy of Family Physicians</pub><pmid>19235496</pmid><tpages>4</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0002-838X |
ispartof | American family physician, 2009-02, Vol.79 (4), p.297-300 |
issn | 0002-838X |
language | eng |
recordid | cdi_proquest_miscellaneous_66951836 |
source | MEDLINE; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals |
subjects | Adrenal Cortex Hormones - administration & dosage Ambulatory Care Anti-Bacterial Agents - administration & dosage Anti-Inflammatory Agents - administration & dosage Antibiotics Drug therapy Family Practice Humans Infections Injections, Intramuscular Internal Medicine Ketorolac - administration & dosage Musculoskeletal system Outpatient care facilities Staphylococcus infections Vitamin B 12 - administration & dosage Vitamin B Complex - administration & dosage |
title | Evidence for the Use of Intramuscular Injections in Outpatient Practice |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-16T09%3A40%3A51IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Evidence%20for%20the%20Use%20of%20Intramuscular%20Injections%20in%20Outpatient%20Practice&rft.jtitle=American%20family%20physician&rft.au=Shatsky,%20Mark,%20DO&rft.date=2009-02-15&rft.volume=79&rft.issue=4&rft.spage=297&rft.epage=300&rft.pages=297-300&rft.issn=0002-838X&rft.coden=AFPYBF&rft_id=info:doi/&rft_dat=%3Cproquest_pubme%3E66951836%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=234316213&rft_id=info:pmid/19235496&rft_els_id=1_s2_0_S0002838X09600848&rfr_iscdi=true |